189 related articles for article (PubMed ID: 36551675)
21. Human papillomavirus type 18 oncoproteins exert their oncogenicity in esophageal and tongue squamous cell carcinoma cell lines distinctly.
Boon SS; Chen Z; Li J; Lee KYC; Cai L; Zhong R; Chan PKS
BMC Cancer; 2019 Dec; 19(1):1211. PubMed ID: 31830929
[TBL] [Abstract][Full Text] [Related]
22. Human papillomavirus (HPV) 16 and the prognosis of head and neck cancer in a geographical region with a low prevalence of HPV infection.
López RV; Levi JE; Eluf-Neto J; Koifman RJ; Koifman S; Curado MP; Michaluart-Junior P; Figueiredo DL; Saggioro FP; de Carvalho MB; Kowalski LP; Abrahão M; de Góis-Filho F; Tajara EH; Waterboer T; Boffetta P; Brennan P; Wünsch-Filho V
Cancer Causes Control; 2014 Apr; 25(4):461-71. PubMed ID: 24474236
[TBL] [Abstract][Full Text] [Related]
23. Mechanistic role of HPV-associated early proteins in cervical cancer: Molecular pathways and targeted therapeutic strategies.
Bhattacharjee R; Das SS; Biswal SS; Nath A; Das D; Basu A; Malik S; Kumar L; Kar S; Singh SK; Upadhye VJ; Iqbal D; Almojam S; Roychoudhury S; Ojha S; Ruokolainen J; Jha NK; Kesari KK
Crit Rev Oncol Hematol; 2022 Jun; 174():103675. PubMed ID: 35381343
[TBL] [Abstract][Full Text] [Related]
24. Construction and characterization of recombinant fowlpox viruses expressing human papilloma virus E6 and E7 oncoproteins.
Pozzi E; Basavecchia V; Zanotto C; Pacchioni S; Morghen Cde G; Radaelli A
J Virol Methods; 2009 Jun; 158(1-2):184-9. PubMed ID: 19428588
[TBL] [Abstract][Full Text] [Related]
25. Quantitation of human papillomavirus 16 E6 and E7 DNA and RNA in residual material from ThinPrep Papanicolaou tests using real-time polymerase chain reaction analysis.
Wang-Johanning F; Lu DW; Wang Y; Johnson MR; Johanning GL
Cancer; 2002 Apr; 94(8):2199-210. PubMed ID: 12001118
[TBL] [Abstract][Full Text] [Related]
26. Involvement of HPV Infection in the Release of Macrophage Migration Inhibitory Factor in Head and Neck Squamous Cell Carcinoma.
Kindt N; Descamps G; Lechien JR; Remmelink M; Colet JM; Wattiez R; Berchem G; Journe F; Saussez S
J Clin Med; 2019 Jan; 8(1):. PubMed ID: 30634708
[TBL] [Abstract][Full Text] [Related]
27. Development of an adenoviral vaccine against E6 and E7 oncoproteins to prevent growth of human papillomavirus-positive cancer.
Lee DW; Anderson ME; Wu S; Lee JH
Arch Otolaryngol Head Neck Surg; 2008 Dec; 134(12):1316-23. PubMed ID: 19075129
[TBL] [Abstract][Full Text] [Related]
28. Periodontal pocket as a potential reservoir of high risk human papilloma virus: A pilot study.
Dayakar MM; Shipilova A; Gupta D
J Indian Soc Periodontol; 2016; 20(2):136-40. PubMed ID: 27143823
[TBL] [Abstract][Full Text] [Related]
29. Cross-talk Signaling between HER3 and HPV16 E6 and E7 Mediates Resistance to PI3K Inhibitors in Head and Neck Cancer.
Brand TM; Hartmann S; Bhola NE; Li H; Zeng Y; O'Keefe RA; Ranall MV; Bandyopadhyay S; Soucheray M; Krogan NJ; Kemp C; Duvvuri U; LaVallee T; Johnson DE; Ozbun MA; Bauman JE; Grandis JR
Cancer Res; 2018 May; 78(9):2383-2395. PubMed ID: 29440171
[TBL] [Abstract][Full Text] [Related]
30. Clinico-pathological peculiarities of human papilloma virus driven head and neck squamous cell carcinoma: A comprehensive update.
Devaraja K; Aggarwal S; Verma SS; Gupta SC
Life Sci; 2020 Mar; 245():117383. PubMed ID: 32007572
[TBL] [Abstract][Full Text] [Related]
31. The HPV 6 E6/E7 transforming genes are expressed in inverted papilloma.
Harris MO; Beck JC; Lancaster W; Gregoire L; Carey TE; Bradford CR
Otolaryngol Head Neck Surg; 1998 Mar; 118(3 Pt 1):312-8. PubMed ID: 9527109
[TBL] [Abstract][Full Text] [Related]
32. The molecular mechanism of human papillomavirus-induced carcinogenesis in head and neck squamous cell carcinoma.
Sano D; Oridate N
Int J Clin Oncol; 2016 Oct; 21(5):819-826. PubMed ID: 27339270
[TBL] [Abstract][Full Text] [Related]
33. Inactivation of the human papillomavirus E6 or E7 gene in cervical carcinoma cells by using a bacterial CRISPR/Cas RNA-guided endonuclease.
Kennedy EM; Kornepati AV; Goldstein M; Bogerd HP; Poling BC; Whisnant AW; Kastan MB; Cullen BR
J Virol; 2014 Oct; 88(20):11965-72. PubMed ID: 25100830
[TBL] [Abstract][Full Text] [Related]
34. Modulation of microRNA-mRNA Target Pairs by Human Papillomavirus 16 Oncoproteins.
Harden ME; Prasad N; Griffiths A; Munger K
mBio; 2017 Jan; 8(1):. PubMed ID: 28049151
[TBL] [Abstract][Full Text] [Related]
35. mTOR inhibition prevents rapid-onset of carcinogen-induced malignancies in a novel inducible HPV-16 E6/E7 mouse model.
Callejas-Valera JL; Iglesias-Bartolome R; Amornphimoltham P; Palacios-Garcia J; Martin D; Califano JA; Molinolo AA; Gutkind JS
Carcinogenesis; 2016 Oct; 37(10):1014-25. PubMed ID: 27538837
[TBL] [Abstract][Full Text] [Related]
36. Head and neck squamous cell carcinoma: Genomics and emerging biomarkers for immunomodulatory cancer treatments.
Solomon B; Young RJ; Rischin D
Semin Cancer Biol; 2018 Oct; 52(Pt 2):228-240. PubMed ID: 29355614
[TBL] [Abstract][Full Text] [Related]
37. Phylogenetic and functional analysis of sequence variation of human papillomavirus type 31 E6 and E7 oncoproteins.
Ferenczi A; Gyöngyösi E; Szalmás A; László B; Kónya J; Veress G
Infect Genet Evol; 2016 Sep; 43():94-100. PubMed ID: 27197052
[TBL] [Abstract][Full Text] [Related]
38. Interaction between 17β-estradiol, prolactin and human papillomavirus induce E6/E7 transcript and modulate the expression and localization of hormonal receptors.
Ramírez-López IG; Ramírez de Arellano A; Jave-Suárez LF; Hernández-Silva CD; García-Chagollan M; Hernández-Bello J; Lopez-Pulido EI; Macias-Barragan J; Montoya-Buelna M; Muñoz-Valle JF; Pereira-Suárez AL
Cancer Cell Int; 2019; 19():227. PubMed ID: 31507337
[TBL] [Abstract][Full Text] [Related]
39. Reciprocal transactivation of Merkel cell polyomavirus and high-risk human papillomavirus promoter activities and increased expression of their oncoproteins.
Rasheed K; Sveinbjørnsson B; Moens U
Virol J; 2021 Jul; 18(1):139. PubMed ID: 34217322
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]